| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.793 | 3.482 | 16.626 | 17.509 | 5.047 | 0 | 3.032 | 0 | 0 | 0 |
| Total Income - EUR | 1.823 | 3.482 | 16.680 | 18.292 | 5.047 | 0 | 3.164 | 0 | 0 | 14 |
| Total Expenses - EUR | 8.065 | 19.481 | 35.422 | 33.431 | 14.822 | 1.094 | 4.285 | 1.201 | 3.447 | 1.975 |
| Gross Profit/Loss - EUR | -6.243 | -15.999 | -18.742 | -15.139 | -9.774 | -1.094 | -1.122 | -1.201 | -3.447 | -1.961 |
| Net Profit/Loss - EUR | -6.297 | -16.034 | -18.909 | -15.322 | -9.825 | -1.094 | -1.122 | -1.201 | -3.447 | -1.961 |
| Employees | 1 | 2 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Patec S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.667 | 1.969 | 1.664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 873 | 1.490 | 627 | 2.295 | 52 | 143 | 282 | 157 | 16 | 29 |
| Inventories | 0 | 473 | 251 | 743 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 1.536 | 31 | 30 | 72 | 30 | 30 | 29 |
| Cash | 873 | 1.017 | 375 | 16 | 21 | 112 | 210 | 128 | -14 | 0 |
| Shareholders Funds | -25.416 | -41.190 | -59.402 | -73.634 | -82.033 | -81.572 | -80.884 | -82.337 | -85.534 | -87.018 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 28.956 | 44.650 | 61.693 | 75.929 | 82.085 | 81.714 | 81.166 | 82.494 | 85.550 | 87.047 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Bio Patec S.r.l.